1. Irm LLC (11 from 151 patents)

2. Wisys Technology Foundation, Inc. (3 from 99 patents)

3. Other (1 from 832,680 patents)

4. Novartis Ag (1 from 3,923 patents)

5. Bristol-myers Squibb Compnay (1 from 3,681 patents)

6. Irm Llc, a Delaware Limited Liability Company (1 from 1 patent)

1. RE47475 - Selective agents for pain suppression

2. 8859574 - Compounds and compositions as kinase inhibitors

3. 8722691 - Azolopyrimidines as inhibitors of cannabinoid 1 activity

4. 8722692 - Compounds and compositions as Syk kinase inhibitors

5. 8519129 - Pyrimidine derivatives as kinase inhibitors

6. 8445505 - Pyrimidine derivatives as kinase inhibitors

7. 8440681 - 2-biphenylamino-4-aminopyrimidine derivatives as kinase inhibitors

8. 8431607 - Compounds and compositions as inhibitors of cannabinoid receptor 1 activity

9. 8362050 - Compounds and methods for modulating G protein-coupled receptors

10. 8158634 - Compounds and compositions as inhibitors of cannabinoid receptor 1 activity

11. 7968557 - Substituted pyrrolo[2,3-2]pyrimidines as protein kinase inhibitors

12. 7601742 - Pyrrolidones with anti-HIV activity

13. 7579363 - Bicyclic compounds and compositions as PDF inhibitors

14. 7495016 - Pyrrolidones with anti-HIV activity

15. 7253164 - Bicyclic compounds and compositions as PDF inhibitors